Literature DB >> 20616169

Heart rate variability predicts ESRD and CKD-related hospitalization.

Daniel J Brotman1, Lori D Bash, Rehan Qayyum, Deidra Crews, Eric A Whitsel, Brad C Astor, Josef Coresh.   

Abstract

Autonomic imbalance, a feature of both diabetes and hypertension, may contribute to adverse cardiovascular outcomes. In animal models, sympathetic nerve activity contributes to renal damage but the extent to which autonomic dysfunction precedes the development of CKD and ESRD in humans is unknown. We measured resting heart rate and heart rate variability in 13,241 adults (45- to 64-years old) followed for a median of 16 years in the Atherosclerosis Risk in Communities (ARIC) Study. We examined heart rate parameters by quartiles, defining those in the lowest quartile (by time and frequency domain measures separately) as the risk group of interest. We identified 199 cases of incident ESRD and 541 patients with CKD-related hospitalizations; higher resting heart rate and lower heart rate variability associated with both outcomes. The fully adjusted hazard ratios for ESRD were 1.98 (95% confidence interval [CI] 1.45 to 2.70) among those in the highest heart rate quartile and 1.56 (95% CI 1.14 to 2.14) for high-frequency power. Other time and frequency domain measures were similarly and significantly associated with ESRD and CKD-related hospitalizations. These results suggest that autonomic dysfunction may be an important risk factor for ESRD and CKD-related hospitalizations and call for further studies to define the mechanisms that underlie these associations.

Entities:  

Mesh:

Year:  2010        PMID: 20616169      PMCID: PMC3013524          DOI: 10.1681/ASN.2009111112

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  59 in total

1.  Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.

Authors:  Michael B Davidson; John K Hix; Donald G Vidt; Daniel J Brotman
Journal:  Arch Intern Med       Date:  2006-04-24

Review 2.  The cardiovascular toll of stress.

Authors:  Daniel J Brotman; Sherita H Golden; Ilan S Wittstein
Journal:  Lancet       Date:  2007-09-22       Impact factor: 79.321

3.  A computer algorithm to impute interrupted heart rate data for the spectral analysis of heart rate variability--the ARIC study.

Authors:  D Liao; R W Barnes; L E Chambless; G Heiss
Journal:  Comput Biomed Res       Date:  1996-04

Review 4.  Sympathetic hyperactivity in chronic renal failure: a wake-up call.

Authors:  Hein A Koomans; Peter J Blankestijn; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

5.  Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.

Authors:  Sharma Prabhakar; Joel Starnes; Shuping Shi; Betty Lonis; Ruc Tran
Journal:  J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 10.121

Review 6.  Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.

Authors:  Robert Toto; Biff F Palmer
Journal:  Am J Nephrol       Date:  2007-12-12       Impact factor: 3.754

7.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

8.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Elizabeth Selvin; Michael Steffes; Josef Coresh; Brad C Astor
Journal:  Arch Intern Med       Date:  2008-12-08

Review 9.  Should beta-blockers be used to control hypertension in people with chronic kidney disease?

Authors:  Peter D Hart; George L Bakris
Journal:  Semin Nephrol       Date:  2007-09       Impact factor: 5.299

10.  The combination of ACE inhibition plus sympathetic denervation is superior to ACE inhibitor monotherapy in the rat renal ablation model.

Authors:  Peter Hamar; Gabor Kokeny; Peter Liptak; Jan Krtil; Marcin Adamczak; Kerstin Amann; Eberhard Ritz; Marie-Luise Gross
Journal:  Nephron Exp Nephrol       Date:  2007-03-07
View more
  71 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study.

Authors:  Paul E Drawz; Denise C Babineau; Carolyn Brecklin; Jiang He; Radhakrishna R Kallem; Elsayed Z Soliman; Dawei Xie; Dina Appleby; Amanda H Anderson; Mahboob Rahman
Journal:  Am J Nephrol       Date:  2013-12-14       Impact factor: 3.754

3.  Predictors of heart rate variability and its prognostic significance in chronic kidney disease.

Authors:  Preeti Chandra; Robin L Sands; Brenda W Gillespie; Nathan W Levin; Peter Kotanko; Margaret Kiser; Fredric Finkelstein; Alan Hinderliter; Rodica Pop-Busui; Sanjay Rajagopalan; Rajiv Saran
Journal:  Nephrol Dial Transplant       Date:  2011-09-12       Impact factor: 5.992

Review 4.  Heart rate and blood pressure: any possible implications for management of hypertension?

Authors:  Scott Reule; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

5.  Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD.

Authors:  Yan Xie; Benjamin Bowe; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-08       Impact factor: 8.237

6.  Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat.

Authors:  Megan S Johnson; Vincent G DeMarco; Cheryl M Heesch; Adam T Whaley-Connell; Rebecca I Schneider; Nathan T Rehmer; Roger D Tilmon; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-05       Impact factor: 4.733

7.  Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.

Authors:  Mee Kyoung Kim; Kyungdo Han; Eun Sil Koh; Hun-Sung Kim; Hyuk-Sang Kwon; Yong-Moon Park; Kun-Ho Yoon; Seung-Hwan Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-31       Impact factor: 8.311

8.  Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Authors:  Ranjani N Moorthi; Simit Doshi; Linda F Fried; Sharon M Moe; Mark J Sarnak; Suzanne Satterfield; Ann V Schwartz; Michael Shlipak; Brittney S Lange-Maia; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Nephrol Dial Transplant       Date:  2019-04-01       Impact factor: 5.992

Review 9.  Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.

Authors:  Jing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-03-29       Impact factor: 2.370

10.  Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease.

Authors:  Shannon B Fadaee; Kassia S Beetham; Erin J Howden; Tony Stanton; Nicole M Isbel; Jeff S Coombes
Journal:  Redox Rep       Date:  2016-04-19       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.